These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 28085026)
21. Purification and characterization of the CK2alpha'-based holoenzyme, an isozyme of CK2alpha: a comparative analysis. Olsen BB; Boldyreff B; Niefind K; Issinger OG Protein Expr Purif; 2006 Jun; 47(2):651-61. PubMed ID: 16442308 [TBL] [Abstract][Full Text] [Related]
22. Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics. Gouron A; Milet A; Jamet H Biophys J; 2014 Mar; 106(5):1134-41. PubMed ID: 24606937 [TBL] [Abstract][Full Text] [Related]
23. Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis. Alvarado-Díaz CP; Tapia JC; Antonelli M; Moreno RD Cell Tissue Res; 2009 Oct; 338(1):139-49. PubMed ID: 19711102 [TBL] [Abstract][Full Text] [Related]
24. Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening. Nienberg C; Garmann C; Gratz A; Bollacke A; Götz C; Jose J Pharmaceuticals (Basel); 2017 Jan; 10(1):. PubMed ID: 28067769 [TBL] [Abstract][Full Text] [Related]
25. Expression and regulation of protein kinase CK2 during the cell cycle. Bosc DG; Lüscher B; Litchfield DW Mol Cell Biochem; 1999 Jan; 191(1-2):213-22. PubMed ID: 10094411 [TBL] [Abstract][Full Text] [Related]
26. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening. Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979 [TBL] [Abstract][Full Text] [Related]
27. Structural and functional determinants of protein kinase CK2α: facts and open questions. Battistutta R; Lolli G Mol Cell Biochem; 2011 Oct; 356(1-2):67-73. PubMed ID: 21739155 [TBL] [Abstract][Full Text] [Related]
28. Structural basis of the constitutive activity of protein kinase CK2. Olsen BB; Guerra B; Niefind K; Issinger OG Methods Enzymol; 2010; 484():515-29. PubMed ID: 21036248 [TBL] [Abstract][Full Text] [Related]
29. Crystal structure of human CK2α at 1.06 Å resolution. Kinoshita T; Nakaniwa T; Sekiguchi Y; Sogabe Y; Sakurai A; Nakamura S; Nakanishi I J Synchrotron Radiat; 2013 Nov; 20(Pt 6):974-9. PubMed ID: 24121351 [TBL] [Abstract][Full Text] [Related]
30. Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid. Sekiguchi Y; Nakaniwa T; Kinoshita T; Nakanishi I; Kitaura K; Hirasawa A; Tsujimoto G; Tada T Bioorg Med Chem Lett; 2009 Jun; 19(11):2920-3. PubMed ID: 19414254 [TBL] [Abstract][Full Text] [Related]
31. Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2. Davis-Gilbert ZW; Krämer A; Dunford JE; Howell S; Senbabaoglu F; Wells CI; Bashore FM; Havener TM; Smith JL; Hossain MA; Oppermann U; Drewry DH; Axtman AD ACS Med Chem Lett; 2023 Apr; 14(4):432-441. PubMed ID: 37077385 [TBL] [Abstract][Full Text] [Related]
32. First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligand. Raaf J; Guerra B; Neundorf I; Bopp B; Issinger OG; Jose J; Pietsch M; Niefind K ACS Chem Biol; 2013 May; 8(5):901-7. PubMed ID: 23474121 [TBL] [Abstract][Full Text] [Related]
33. Primary and secondary interactions between CK2alpha and CK2beta lead to ring-like structures in the crystals of the CK2 holoenzyme. Niefind K; Issinger OG Mol Cell Biochem; 2005 Jun; 274(1-2):3-14. PubMed ID: 16335523 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of cats. Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K Am J Vet Res; 2017 Aug; 78(8):946-953. PubMed ID: 28738012 [TBL] [Abstract][Full Text] [Related]
35. A novel allosteric site in casein kinase 2α discovered using combining bioinformatics and biochemistry methods. Jiang HM; Dong JK; Song K; Wang TD; Huang WK; Zhang JM; Yang XY; Shen Y; Zhang J Acta Pharmacol Sin; 2017 Dec; 38(12):1691-1698. PubMed ID: 28748912 [TBL] [Abstract][Full Text] [Related]
36. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2. Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557 [TBL] [Abstract][Full Text] [Related]
37. Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells. Villamañan L; Alcaraz E; Pinna LA; Ruzzene M; Itarte E; Arús C; Plana M; Candiota AP Pathol Oncol Res; 2019 Oct; 25(4):1659-1663. PubMed ID: 30607803 [TBL] [Abstract][Full Text] [Related]
38. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA). Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539 [TBL] [Abstract][Full Text] [Related]
39. Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activity. Donella-Deana A; Cesaro L; Sarno S; Ruzzene M; Brunati AM; Marin O; Vilk G; Doherty-Kirby A; Lajoie G; Litchfield DW; Pinna LA Biochem J; 2003 Jun; 372(Pt 3):841-9. PubMed ID: 12628006 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit. Baier A; Nazaruk J; Galicka A; Szyszka R Mol Cell Biochem; 2018 Jul; 444(1-2):35-42. PubMed ID: 29188536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]